Literature DB >> 3976702

Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.

G D Borowski, C D Garofano, L I Rose, S R Spielman, H R Rotmensch, A M Greenspan, L N Horowitz.   

Abstract

Both hyperthyroidism and hypothyroidism have been noted to occur in some patients treated with amiodarone for cardiac arrhythmias. To determine the frequency of the development of thyroidal abnormalities in patients receiving amiodarone, 45 euthyroid patients were prospectively evaluated. Serum samples were obtained for measurement of thyroxine, thyrotropin, triiodothyronine, and triiodothyronine resin uptake prior to initiation of amiodarone treatment and serially over a 12- to 27-month period during which amiodarone was administered. The patients were divided into four subgroups as follows: Group I (n = 22) had elevated thyroxine levels, Group IIA (n = 13) had normal thyroxine levels and normal thyrotropin levels, Group IIB (n = 7) had normal thyroxine levels and elevated thyrotropin levels, and Group III (n = 3) had subnormal thyroxine levels. Demographic factors (such as route of administration, cardiac diagnosis, sex of the patient, or indication for amiodarone therapy) and amiodarone levels had no significant effect on the thyroid hormone parameters. However, Group I patients were statistically older than the patients in the other groups. Linear regression analysis revealed a negative correlation for thyroxine levels and a positive correlation with thyrotropin levels with age for the whole group. The various groups were not statistically affected by duration of therapy, but a positive trend existed for increasing thyroxine levels. Although virtually all patients showed changes in their thyroid hormone levels, chemical hyperthyroidism (elevated thyroxine and triiodothyronine levels without symptoms) developed in only two patients (4 percent), and clinical hyperthyroidism (elevated thyroxine and triiodothyronine levels with symptoms) developed in no patients. Four patients (9 percent) became biochemically and clinically hypothyroid. Thus, amiodarone frequently influences thyroid hormonal parameters, but less commonly causes a change in actual thyroid function. However, hyperthyroidism and hypothyroidism do occur in a significant number of patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976702     DOI: 10.1016/0002-9343(85)90336-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Plasma cell granuloma of the thyroid associated with Hashimoto's thyroiditis.

Authors:  M Zingrillo; B Tardio; M Bisceglia
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

2.  Amiodarone-related cyclic thyroid dysfunction.

Authors:  E Salamon; R C Rowe; C Faiman
Journal:  CMAJ       Date:  1989-12-15       Impact factor: 8.262

3.  Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone.

Authors:  E Monteiro; A Galvão-teles; M L Santos; L Mourão; M J Correia; J Lopo Tuna; C Ribeiro
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

4.  Unusual and early hyperglycemia following amiodarone infusion in two infants.

Authors:  S V Yildirim; E Azak; B Varan; K Tokel
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

5.  Use of plasma iodine assay for diagnosing thyroid disorders.

Authors:  P Allain; S Berre; N Krari; P Lainé-Cessac; A Le Bouil; N Barbot; V Rohmer; J C Bigorgne
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

6.  Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.

Authors:  Andrea Hofmann; Clemens Nawara; Sedat Ofluoglu; Johannes Holzmannhofer; Bernhard Strohmer; Christian Pirich
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

7.  Myopathy during amiodarone treatment: a case report.

Authors:  F Carella; E Riva; L Morandi; E Cappiello; A Mangoni
Journal:  Ital J Neurol Sci       Date:  1987-12

8.  Thyroid disorders in the elderly. Difficulties in diagnosis and treatment.

Authors:  A J Campbell
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

9.  Risk factors for amiodarone-induced thyroid dysfunction in Japan.

Authors:  Sayoko Kinoshita; Tomohiro Hayashi; Kyoichi Wada; Mikie Yamato; Takeshi Kuwahara; Toshihisa Anzai; Mai Fujimoto; Kouichi Hosomi; Mitsutaka Takada
Journal:  J Arrhythm       Date:  2016-05-05

10.  Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients.

Authors:  Toyoyoshi Uchida; Takatoshi Kasai; Atsutoshi Takagi; Gaku Sekita; Koji Komiya; Kageumi Takeno; Nayumi Shigihara; Kazunori Shimada; Katsumi Miyauchi; Yoshio Fujitani; Hiroyuki Daida; Hirotaka Watada
Journal:  Int J Endocrinol       Date:  2014-06-25       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.